STOCK TITAN

ICF Appoints New Head of Corporate Development

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
management

ICF (NASDAQ:ICFI) has appointed Dr. Eric Hakimov as vice president of corporate development to lead the company's M&A growth strategy and integration efforts. Hakimov brings over 20 years of experience in strategic corporate transitions, investment banking, and private equity, having completed more than 35 transactions worth over $b>$17 billion globally. With both MD and MBA degrees, his background combines medical and business expertise. Previously, he held leadership positions at Labcorp, IQVIA, Monument Capital Group, and JPMorgan. He will focus on ICF's key growth markets including federal health, energy, disaster management, climate services, and federal digital modernization.

ICF (NASDAQ:ICFI) ha nominato Dr. Eric Hakimov come vicepresidente dello sviluppo aziendale per guidare la strategia di crescita in materia di fusioni e acquisizioni e gli sforzi di integrazione dell'azienda. Hakimov porta con sé oltre 20 anni di esperienza in transizioni strategiche aziendali, investment banking e private equity, avendo completato più di 35 operazioni per un valore complessivo superiore a $17 miliardi a livello globale. Con una formazione in Medicina e un MBA, la sua esperienza combina competenze mediche e aziendali. In precedenza, ha ricoperto posizioni di leadership in Labcorp, IQVIA, Monument Capital Group e JPMorgan. Si concentrerà sui principali mercati di crescita di ICF, tra cui salute federale, energia, gestione delle crisi, servizi climatici e modernizzazione digitale federale.

ICF (NASDAQ:ICFI) ha nombrado a Dr. Eric Hakimov como vicepresidente de desarrollo corporativo para liderar la estrategia de crecimiento de fusiones y adquisiciones e integrar los esfuerzos de la empresa. Hakimov aporta más de 20 años de experiencia en transiciones corporativas estratégicas, banca de inversión y capital privado, habiendo completado más de 35 transacciones por un valor superior a $17 mil millones a nivel mundial. Con títulos de MD y MBA, su experiencia combina conocimientos médicos y empresariales. Anteriormente, ocupó posiciones de liderazgo en Labcorp, IQVIA, Monument Capital Group y JPMorgan. Se centrará en los principales mercados de crecimiento de ICF, incluyendo salud federal, energía, gestión de desastres, servicios climáticos y modernización digital federal.

ICF (NASDAQ:ICFI)는 Dr. Eric Hakimov을 기업 개발 부사장으로 임명하여 회사의 M&A 성장 전략과 통합 작업을 이끌게 하였습니다. Hakimov는 전략적 기업 전환, 투자은행 및 사모펀드 분야에서 20년 이상의 경험을 보유하고 있으며, 글로벌로 $17억 달러 이상의 가치로 35건 이상의 거래를 완료했습니다. 그는 MD와 MBA 학위를 소지하고 있으며, 의료와 비즈니스 전문 지식을 결합한 배경을 가지고 있습니다. 이전에는 Labcorp, IQVIA, Monument Capital Group 및 JPMorgan에서 리더십 직책을 역임했습니다. 그는 ICF의 주요 성장 시장, 즉 연방 건강, 에너지, 재해 관리, 기후 서비스 및 연방 디지털 현대화에 집중할 예정입니다.

ICF (NASDAQ:ICFI) a nommé Dr. Eric Hakimov au poste de vice-président du développement corporate pour diriger la stratégie de croissance en matière de fusions et acquisitions ainsi que les efforts d'intégration de l'entreprise. Hakimov apporte plus de 20 ans d'expérience dans les transitions stratégiques d'entreprise, la banque d'investissement et le capital-investissement, ayant réalisé plus de 35 transactions d'une valeur supérieure à $17 milliards à l'échelle mondiale. Possédant un diplôme de MD et un MBA, son parcours allie expertise médicale et commerciale. Auparavant, il a occupé des postes de direction chez Labcorp, IQVIA, Monument Capital Group et JPMorgan. Il se concentrera sur les principaux marchés de croissance d'ICF, notamment la santé fédérale, l'énergie, la gestion des catastrophes, les services liés au climat et la modernisation numérique fédérale.

ICF (NASDAQ:ICFI) hat Dr. Eric Hakimov zum Vizepräsidenten für Unternehmensentwicklung ernannt, um die Wachstumsstrategie des Unternehmens im Bereich Fusionen und Übernahmen sowie die Integrationsbemühungen zu leiten. Hakimov bringt über 20 Jahre Erfahrung in strategischen Unternehmensübergängen, Investmentbanking und Private Equity mit und hat mehr als 35 Transaktionen im Wert von über $17 Milliarden weltweit abgeschlossen. Mit Abschlüssen als MD und MBA kombiniert sein Hintergrund medizinisches und geschäftliches Fachwissen. Zuvor hatte er Führungspositionen bei Labcorp, IQVIA, Monument Capital Group und JPMorgan inne. Er wird sich auf die wichtigsten Wachstumsmärkte von ICF konzentrieren, darunter föderale Gesundheitsdienste, Energie, Katastrophenmanagement, Klimadienste und die digitale Modernisierung des Bundes.

Positive
  • Appointment of experienced M&A executive with track record of $17B in completed transactions
  • Strategic hire brings valuable banking sector relationships and market knowledge
  • Dual MD/MBA background aligns with ICF's health and technology focus
Negative
  • None.

Eric Hakimov to Lead M&A Strategy and Integration Efforts 

RESTON, Va., Nov. 4, 2024 /PRNewswire/ -- ICF (NASDAQ:ICFI), a global consulting and technology services provider, today announced Dr. Eric Hakimov as their new vice president of corporate development. In this role, Hakimov will be responsible for driving the company's merger and acquisition (M&A) growth strategy and managing the company's integration efforts.  

Hakimov brings over 20 years of experience across strategic corporate transitions, investment banking and private equity to ICF. His expertise includes acquisitions, divestitures, strategic partnerships, joint ventures, corporate venture capital investments, restructuring and debt and equity financing. Prior to joining ICF, Hakimov held a number of leadership positions at firms such as Labcorp, IQVIA, Monument Capital Group and JPMorgan. To date, he has completed over 35 transactions globally, deploying over $17 billion in capital across a range of industries.

With formal training as both a physician and business leader, Hakimov holds an MD and an MBA. His combined background in both science and business strategy will help guide ICF's strategic investments across the company's key growth markets from federal health and health technology to energy, disaster management, climate and infrastructure services, federal digital modernization, and more.

"Eric has worked on both small and large transactions in the U.S. and internationally and is very well-suited to help ICF continue to execute on our M&A efforts," said James Morgan, ICF chief operating officer. "An excellent communicator and negotiator, he brings key relationships within the banking sector and extensive knowledge of the markets we serve. I look forward to the innovative approaches and strategic insights Eric will bring to our corporate development and M&A initiatives."

"I'm thrilled to join such a dynamic and purpose-driven firm at this pivotal moment of growth," said Hakimov. "The opportunity to contribute to a company that consistently aligns its strategic acquisitions to a clear purpose of creating lasting, positive impact is truly exciting. I look forward to supporting ICF's continued success and expanding our reach in ways that not only strengthen the business, but furthers our commitment to making a meaningful difference for our clients."

About ICF
ICF is a global consulting and technology services company with approximately 9,000 employees, but we are not your typical consultants. At ICF, business analysts and policy specialists work together with digital strategists, data scientists and creatives. We combine unmatched industry expertise with cutting-edge engagement capabilities to help organizations solve their most complex challenges. Since 1969, public and private sector clients have worked with ICF to navigate change and shape the future. Learn more at icf.com.

Caution Concerning Forward-looking Statements
Statements that are not historical facts and involve known and unknown risks and uncertainties are "forward-looking statements" as defined in the Private Securities Litigation Reform Act of 1995. Such statements may concern our current expectations about our future results, plans, operations and prospects and involve certain risks, including those related to the government contracting industry generally; our particular business, including our dependence on contracts with U.S. federal government agencies; our ability to acquire and successfully integrate businesses; and various risks and uncertainties related to health epidemics, pandemics, and similar outbreaks. These and other factors that could cause our actual results to differ from those indicated in forward-looking statements that are included in the "Risk Factors" section of our securities filings with the Securities and Exchange Commission. The forward-looking statements included herein are only made as of the date hereof, and we specifically disclaim any obligation to update these statements in the future.

Contact: Lauren Dyke, lauren.dyke@ICF.com, +1.571.373.5577

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/icf-appoints-new-head-of-corporate-development-302294848.html

SOURCE ICF

FAQ

Who is the new head of corporate development at ICF (ICFI)?

Dr. Eric Hakimov has been appointed as ICF's new vice president of corporate development to lead M&A strategy and integration efforts.

What is Dr. Eric Hakimov's experience before joining ICF (ICFI)?

Hakimov has over 20 years of experience in corporate transitions, investment banking, and private equity, having completed over 35 transactions worth $17 billion globally. He previously held leadership positions at Labcorp, IQVIA, Monument Capital Group, and JPMorgan.

What areas will Dr. Hakimov focus on at ICF (ICFI)?

He will focus on ICF's key growth markets including federal health, health technology, energy, disaster management, climate and infrastructure services, and federal digital modernization.

ICF International, Inc.

NASDAQ:ICFI

ICFI Rankings

ICFI Latest News

ICFI Stock Data

3.04B
18.50M
1.39%
97.33%
0.91%
Consulting Services
Services-management Consulting Services
Link
United States of America
RESTON